Beijing SL Pharmaceutical Co Ltd Sustainability Reports
The company develops, manufactures, and markets genetic engineering and biochemical drugs. Its product portfolio mainly targets oncology, hepatopathy, and cardiovascular therapies.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG001SBRQP8
2 reports from 2018 to 2024
